• Home
  • Investors
    • News Archive
    • Share Information
      • Shareholder Service
      • General Meetings
    • Reports
    • Board and Management
  • Contact

You are here

Home » Investors

News

Nordiag Q2 2007
Presentation of the second quarter 2007
Letter to the shareholders
Case study from NorDiag published in August
Oslo Børs - Matching halt ends
Oslo Børs - Matching halt
Public reimbursement of the Genefec test discontinued in Norway from 1 September
EXACT Sciences and NorDiag Announce International Collaboration and License Agreement for Colorectal Cancer
NorDiag has entered into a distribution agreement with Roche
Mottatt firmaattest
NorDiag: New product for tailored medicine
NorDiag Q1 07
GE Healthcare grants license to NorDiag ASA
Annual Information
NorDiag to enter the US-market
New NorDiag product
Presentation of the first quarter 2007
General meeting
Share issue
Mandatory notification of trade

Pages

  • « first
  • ‹ previous
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • next ›
  • last »
News archive

NORDA ASA  ♦  Stortingsgaten 28  ♦   0161 Oslo  ♦   Norway  ♦   Phone: +47 924 23 561  ♦   web: www.nordasa.no